Workflow
Crystal-Optech(002273)
icon
Search documents
水晶光电: 第七届董事会第三次会议决议公告
Zheng Quan Zhi Xing· 2025-09-05 09:17
Group 1 - The company held its third meeting of the seventh board of directors on September 5, 2025, with all 12 directors present, and the meeting was conducted via telecommunication [1] - The board approved a proposal for purchasing equipment assets from an affiliated party, with 11 votes in favor and no votes against or abstentions [1] - The independent directors had previously reviewed the related transaction in a special meeting [1] Group 2 - The company agreed to purchase coating equipment from the affiliated company Optoran for a total amount of 33,600 million Japanese yen, approximately 16.13 million RMB, which represents 0.18% of the company's audited net assets for 2024 [2] - The cumulative transactions with the same related party, Japan Koguchi, exceeded 3 million RMB within the last twelve months, reaching 0.5% of the company's most recent audited net assets [2] - The related transaction was approved by the board and does not require shareholder approval according to relevant regulations [2]
水晶光电(002273.SZ):拟向参股公司日本光驰购买镀膜设备
Ge Long Hui A P P· 2025-09-05 08:56
Group 1 - The company, Crystal Optoelectronics (002273.SZ), plans to purchase coating equipment from its affiliate, Optoran Co., Ltd. (Japan), for a total amount of 336 million Japanese yen, which is approximately 16.1253 million RMB based on the exchange rate as of September 5, 2025 [1] - The transaction amount represents 0.18% of the company's audited net assets for 2024 [1]
水晶光电拟向日本光驰购买镀膜设备 拓展光学产品线矩阵
Zhi Tong Cai Jing· 2025-09-05 08:46
Core Viewpoint - The company plans to purchase coating equipment from its affiliate, Japan Koguchi, for a total amount of 336 million yen, which will enhance its optical application innovation opportunities and accelerate the transformation and upgrading of its consumer electronics business [1] Group 1 - The total transaction amount for the coating equipment purchase is 336 million yen [1] - Japan Koguchi specializes in the research, production, and sales of coating equipment and core components for optical and touch panel industries [1] - The acquisition of the coating equipment is expected to expand the company's optical product line matrix [1]
水晶光电(002273) - 关于公司购买设备资产暨关联交易的公告
2025-09-05 08:45
证券代码:002273 股票简称:水晶光电 公告编号:(2025)064 号 浙江水晶光电科技股份有限公司 关于公司购买设备资产暨关联交易的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、 误导性陈述或重大遗漏。 一、关联交易概述 1、浙江水晶光电科技股份有限公司(以下简称"公司")因业务发展需要,拟向公司 之参股公司株式会社オプトラン(以下简称"日本光驰")购买镀膜设备,交易总金额为 33,600.00 万日元(按 2025 年 9 月 5 日汇率约合人民币 1,612.53 万元),占公司 2024 年 经审计净资产的 0.18%。 2、根据《深圳证券交易所股票上市规则》相关规定,公司持有日本光驰 16.33%的股权, 为第一大股东,且公司董事林敏先生担任日本光驰董事,上述交易构成关联交易。 资本金:4 亿日元 社长:范宾 注册地:埼玉县鹤岛市富士见 6 丁目 1 番 1 企业法人号:0300-01-056764 经营范围:真空成膜产品的制造销售以及进出口;真空成膜装置以及周边设备的制造、 销售以及进出口;真空成膜装置以及周边设备的维护业务;使用真空成膜产品的装置方案设 计销 ...
水晶光电(002273) - 第七届董事会独立董事专门会议2025年第一次会议决议
2025-09-05 08:45
浙江水晶光电科技股份有限公司 第七届董事会独立董事专门会议 2025 年第一次会议决议 浙江水晶光电科技股份有限公司(以下简称"公司")第七届董事会独立董事专门会议 2025 年第一次会议通知于 2025 年 9 月 3 日以微信、电话和口头的形式发出。为提高决策效 率并经全体独立董事一致同意,本次独立董事专门会议豁免通知时限要求。会议于 2025 年 9 月 4 日上午 09:00 以通讯表决的方式召开。本次会议由全体独立董事共同推举张宏旺先生召 集并主持,会议应出席独立董事 4 名,实际出席独立董事 4 名。本次会议的召开符合法律、 法规、规章及公司章程的规定。 会议形成如下决议: [本页无正文,为第七届董事会独立董事专门会议 2025 年第一次会议决议签字页] 签字:________________ 李宗彦 签字:________________ 甘为民 签字:________________ 张宏旺 审议通过了《关于公司购买设备资产暨关联交易的议案》。 表决结果:同意 4 票,反对 0 票,弃权 0 票。 经审核,我们认为:公司本次拟向日本光驰购买镀膜设备而产生的关联交易属于正常的 商业交易行为,其交 ...
水晶光电(002273) - 第七届董事会第三次会议决议公告
2025-09-05 08:45
证券代码:002273 股票简称:水晶光电 公告编号:(2025)063 号 浙江水晶光电科技股份有限公司 一、董事会会议召开情况 浙江水晶光电科技股份有限公司(以下简称"公司")第七届董事会第三次会议通知于 2025 年 9 月 4 日以微信、电话和口头的形式发出。根据《董事会议事规则》的有关规定并 经全体董事一致同意,本次董事会会议豁免通知时限要求。会议于 2025 年 9 月 5 日上午 9:00 以通讯表决的方式召开。本次会议应出席董事 12 人,实际出席董事 12 人,会议由董事长李 夏云女士主持。本次会议的召开符合法律、法规、规章及公司章程的规定。 二、董事会会议审议情况 审议通过了《关于公司购买设备资产暨关联交易的议案》。 表决结果:关联董事林敏回避表决,同意 11 票,反对 0 票,弃权 0 票。 本次关联交易事项已经第七届董事会独立董事专门会议 2025 年第一次会议审议通过。 第七届董事会第三次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整,没有虚假记载、 误导性陈述或重大遗漏。 董事会同意公司向关联方株式会社オプトラン购买镀膜设备,交易总金额为 33,600.00 ...
水晶光电:9月5日召开董事会会议
Mei Ri Jing Ji Xin Wen· 2025-09-05 08:41
Group 1 - The company Crystal Optoelectronics (SZ 002273) held its third meeting of the seventh board of directors on September 5, 2025, via telecommunication voting, discussing the proposal for purchasing equipment assets and related transactions [1] - For the first half of 2025, the revenue composition of Crystal Optoelectronics was as follows: 92.2% from the optical optoelectronics industry, 6.21% from reflective materials, and 1.6% from other businesses [1] - As of the report date, the market capitalization of Crystal Optoelectronics was 36.1 billion yuan [1] Group 2 - The article discusses the challenges faced by Haidilao, noting that the survival rate of its sub-brands is less than 50% [1]
水晶光电(002273.SZ)拟向日本光驰购买镀膜设备 拓展光学产品线矩阵
智通财经网· 2025-09-05 08:39
Group 1 - The company plans to purchase coating equipment from its affiliate, Japan Koguchi, for a total amount of 336 million yen [1] - Japan Koguchi specializes in the research, production, and sales of coating equipment and core components for optical and touch panel industries, with precision coating equipment being its main product [1] - This acquisition is expected to help the company seize opportunities in optical application innovations, expand its optical product line, and accelerate the transformation and upgrading of its consumer electronics business [1]
水晶光电涨2.01%,成交额10.59亿元,主力资金净流入3762.91万元
Xin Lang Cai Jing· 2025-09-05 07:38
Group 1 - The core viewpoint of the news is that Crystal Optoelectronics has shown significant stock performance and financial growth, with a notable increase in share price and market capitalization [1][2] - As of September 5, the stock price of Crystal Optoelectronics rose by 2.01% to 25.89 CNY per share, with a total market capitalization of 36.003 billion CNY [1] - The company has experienced a year-to-date stock price increase of 17.56%, with a 6.94% decline over the last five trading days, but a 24.29% increase over the last 20 days and a 37.27% increase over the last 60 days [1] Group 2 - Crystal Optoelectronics, established on August 2, 2002, and listed on September 19, 2008, specializes in optical imaging, film optical panels, automotive electronics (AR+), and reflective materials [2] - The company's revenue composition includes 84.20% from consumer electronics, 8.00% from automotive electronics (AR+), 6.21% from reflective materials, and 1.60% from other sources [2] - For the first half of 2025, Crystal Optoelectronics achieved a revenue of 3.02 billion CNY, representing a year-on-year growth of 13.77%, and a net profit attributable to shareholders of 501 million CNY, up 17.35% year-on-year [2] Group 3 - As of June 30, 2025, the top ten circulating shareholders of Crystal Optoelectronics include Hong Kong Central Clearing Limited, which holds 57.3245 million shares, a decrease of 53.4496 million shares from the previous period [3] - Southern CSI 500 ETF ranks as the fourth largest circulating shareholder with 20.6180 million shares, an increase of 2.8256 million shares [3] - In addition, Invesco Great Wall Quality Evergreen Mixed A has entered as a new shareholder, holding 15.8310 million shares [3]
9月3日晚间重要公告一览
Xi Niu Cai Jing· 2025-09-03 10:18
Group 1 - Shengtun Mining plans to repurchase shares worth between 500 million and 600 million yuan, with a maximum repurchase price of 11.82 yuan per share, aimed at employee stock ownership plans or equity incentives [1] - Kangnbei received a drug registration certificate for Linggui Shugan Granules, which is derived from traditional Chinese medicine and is used for treating phlegm and dampness due to Yang deficiency [2] - Zhangjiang Hi-Tech intends to publicly transfer 100% equity and related debts of Shanghai Jixin Rui Construction Technology Co., Ltd. with a total price not less than 151 million yuan [3] Group 2 - Shankai Intelligent won a bid for a metering device procurement project worth 13.318 million yuan from Hohhot Water Supply Company [4] - Hason Co. plans to jointly establish a supply chain company with a registered capital of 10 million yuan, in which Hason will hold a 10% stake [5] - Pudong Construction's subsidiaries won multiple major projects with a total amount of 1.271 billion yuan [6] Group 3 - Jinling Pharmaceutical received approval for the Phase III clinical trial of Olaratogrel tablets, which are used for treating moderate to severe pain associated with endometriosis [8] - Menohua's subsidiary obtained a drug registration certificate for Mosapride Citrate Tablets, aimed at improving gastrointestinal symptoms [10] - Shapuaisi's major shareholder plans to reduce holdings by up to 2% of the company's shares due to personal financial needs [11] Group 4 - Changyuan Power reported an August electricity generation of 3.771 billion kWh, a year-on-year decrease of 6.03% [15][16] - Xibu Livestock's August fresh milk production increased by 4.8% month-on-month but decreased by 7.27% year-on-year [19] - Yong'an Pharmaceutical's actual controller and chairman had their detention lifted, allowing them to resume normal duties [20] Group 5 - Jinkai Intelligent's director resigned due to work adjustments [22] - Xinhua Medical received a Class II medical device registration for an endoscope cleaning workstation [23] - Haishi Science and Technology's innovative drug HSK47388 received approval for a new indication clinical trial [25] Group 6 - Baotai Co. plans to participate in a land use rights auction in Baoji City with a starting price of 57.34 million yuan [26] - Minfeng Special Paper received a government subsidy totaling 11.2 million yuan [27] - Jiuchang Bio obtained a medical device registration for a heparin-binding protein assay kit [29] Group 7 - Jingao Technology plans to repurchase shares worth between 200 million and 400 million yuan, with a maximum price of 17.36 yuan per share [31] - Youxunda won a bid for a metering equipment project from China Southern Power Grid worth approximately 161 million yuan [32] - Qianli Technology reported an August vehicle sales increase of 168.55% year-on-year [32] Group 8 - Guangzhou Port expects an August container throughput increase of 1.2% year-on-year [32] - Kexing Pharmaceutical's GB08 injection completed the first subject enrollment for Phase II clinical trials [33] - Wu Ming Pharmaceutical plans to transfer 98.9% of its subsidiary's shares to a newly established wholly-owned subsidiary [34] Group 9 - Shanghai Electric's acquisition of K-Electric Limited shares has not yet completed the transfer [35] - Fulai New Materials plans to raise no more than 710 million yuan through a private placement [36] - Huaren Health's drug registration application for a new type of potassium ion competitive acid blocker has been accepted [37]